Medpace Holdings, Inc. MEDP | NASDAQ
After Hours
Company Overview:
5.9 Year Performance Metrics:
MEDP Dividend Payments, Yield & Share Price charts
Unlock All Reports & Research Dividend Stocks like a BOSS!
MEDP Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.
Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.
Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.
FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.
Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.
MEDP Earnings, Revenue, Cash & Debt, Shares Outstaning:
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
Ratios, Profit Margins & Return on Capital:
MEDP Dividends Info:
MEDP Dividend History: Dates, Payments & Yield list
Below is a schedule of all MEDP dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield
Ex-Date | Payment Date | Amount | TTM Yield | Forward Yield | Price on Ex-Date |
---|
Get the best Dividend Stock Research Tools:
Projected Future Returns & Dividends for MEDP
Based on past 5.9-year performance, here are MEDP growth metrics:Using MEDP CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:
Share price CAGR of +31.92%
Dividend CAGR of +0%
MEDP | |
---|---|
Current Price | $337.28 |
Start Shares | 29.65 |
Start Value | $10,000 |
After 10 years: | |
Final Share Count | 29.65 |
Dividends Payment | $0.00 |
Annual Dividends | $0 |
Yield on cost | 0.00% |
Share Price | $4,081.05 |
Total Dividends | $0 |
Final Value | $120,999 |
NOTE: Above numbers are our estimate based on MEDP's Dividend and Price CAGR over past 5.9 years.
These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).
We cannot guarantee that your actual returns will meet these estimates.
Company Info
Medpace Holdings, Inc. (MEDP) had its IPO on 2016-08-11, and is trader on NASDAQ stock exchange.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
MEDP website: https://www.medpace.com